Bellus Health

Biopharma’s green shoots thriving in summer sun as deal activity returns
Biopharma’s green shoots thriving in summer sun as deal activity returns
Fierce Biotech
M&A
Eli Lilly
Siglion Therapeutics
DiCE Therapeutics
GSK
Bellus Health
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
Flag link:
GSK coughs up $2B for Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
GSK
Bellus Health
M&A
chronic cough
Camlipixant
Flag link:
Biopharma’s stock market winners of 2021 revealed
Biopharma’s stock market winners of 2021 revealed
EP Vantage
biotech stocks
Eli Lilly
Pfizer
Abbott Labs
Moderna Therapeutics
Merck KGaA
Novo Nordisk
BioNTech
Biohaven
Prothena
Bicycle Therapeutics
Bellus Health
Evolus
Flag link:
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis
Endpoints
Bellus Health
chronic cough
Merck
BLU-5937
gefapixant
Flag link:
Bellus says its Merck cough rival passed a PhIIb test after earlier flop, but investors can't make up their minds
Bellus says its Merck cough rival passed a PhIIb test after earlier flop, but investors can't make up their minds
Endpoints
Bellus Health
chronic cough
Merck
clinical trials
Flag link:
Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street
Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street
Endpoints
Bellus Health
BLU-5937
clinical trials
chronic cough
Flag link:
Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug
Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug
Endpoints
Bellus Health
IPOs
chronic cough
Merck
Flag link:
CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA
CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA
PR-Canada.net
Celtic Therapeutics
Bellus Health
Kiacta
AA amyloidosis
rheumatoid arthritis
Flag link: